Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 23(6)2022 Mar 15.
Article in English | MEDLINE | ID: mdl-35328561

ABSTRACT

LTA4H is a bifunctional zinc metalloenzyme that converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), one of the most potent chemotactic agents involved in acute and chronic inflammatory diseases. In this reaction, LTA4H acts as an epoxide hydrolase with a unique and fascinating mechanism, which includes the stereoselective attachment of one water molecule to the carbon backbone of LTA4 several methylene units away from the epoxide moiety. By combining Molecular Dynamics simulations and Quantum Mechanics/Molecular Mechanics calculations, we obtained a very detailed molecular picture of the different consecutive steps of that mechanism. By means of a rather unusual 1,7-nucleophilic substitution through a clear SN1 mechanism, the epoxide opens and the triene moiety of the substrate twists in such a way that the bond C6-C7 adopts its cis (Z) configuration, thus exposing the R face of C12 to the addition of a water molecule hydrogen-bonded to ASP375. Thus, the two stereochemical features that are required for the bioactivity of LTB4 appear to be closely related. The noncovalent π-π stacking interactions between the triene moiety and two tyrosines (TYR267 and, especially, TYR378) that wrap the triene system along the whole reaction explain the preference for the cis configuration inside LTA4H.


Subject(s)
Epoxide Hydrolases , Leukotriene B4 , Epoxide Hydrolases/chemistry , Epoxy Compounds , Leukotriene A4/chemistry , Water
2.
J Biol Chem ; 291(35): 18410-8, 2016 08 26.
Article in English | MEDLINE | ID: mdl-27365393

ABSTRACT

Leukotriene C4 synthase (LTC4S) catalyzes the formation of the proinflammatory lipid mediator leukotriene C4 (LTC4). LTC4 is the parent molecule of the cysteinyl leukotrienes, which are recognized for their pathogenic role in asthma and allergic diseases. Cellular LTC4S activity is suppressed by PKC-mediated phosphorylation, and recently a downstream p70S6k was shown to play an important role in this process. Here, we identified Ser(36) as the major p70S6k phosphorylation site, along with a low frequency site at Thr(40), using an in vitro phosphorylation assay combined with mass spectrometry. The functional consequences of p70S6k phosphorylation were tested with the phosphomimetic mutant S36E, which displayed only about 20% (20 µmol/min/mg) of the activity of WT enzyme (95 µmol/min/mg), whereas the enzyme activity of T40E was not significantly affected. The enzyme activity of S36E increased linearly with increasing LTA4 concentrations during the steady-state kinetics analysis, indicating poor lipid substrate binding. The Ser(36) is located in a loop region close to the entrance of the proposed substrate binding pocket. Comparative molecular dynamics indicated that Ser(36) upon phosphorylation will pull the first luminal loop of LTC4S toward the neighboring subunit of the functional homotrimer, thereby forming hydrogen bonds with Arg(104) in the adjacent subunit. Because Arg(104) is a key catalytic residue responsible for stabilization of the glutathione thiolate anion, this phosphorylation-induced interaction leads to a reduction of the catalytic activity. In addition, the positional shift of the loop and its interaction with the neighboring subunit affect active site access. Thus, our mutational and kinetic data, together with molecular simulations, suggest that phosphorylation of Ser(36) inhibits the catalytic function of LTC4S by interference with the catalytic machinery.


Subject(s)
Glutathione Transferase/chemistry , Amino Acid Substitution , Animals , Binding Sites , Catalysis , Glutathione Transferase/genetics , Glutathione Transferase/metabolism , Humans , Leukotriene A4/biosynthesis , Leukotriene A4/chemistry , Leukotriene A4/genetics , Mice , Mutation, Missense , Phosphorylation , Protein Structure, Secondary , Ribosomal Protein S6 Kinases, 70-kDa/chemistry , Ribosomal Protein S6 Kinases, 70-kDa/genetics , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Serine/chemistry , Serine/genetics , Serine/metabolism
3.
J Biol Chem ; 289(51): 35314-25, 2014 Dec 19.
Article in English | MEDLINE | ID: mdl-25371198

ABSTRACT

Calcium/voltage-gated, large conductance potassium (BK) channels control numerous physiological processes, including myogenic tone. BK channel regulation by direct interaction between lipid and channel protein sites has received increasing attention. Leukotrienes (LTA4, LTB4, LTC4, LTD4, and LTE4) are inflammatory lipid mediators. We performed patch clamp studies in Xenopus oocytes that co-expressed BK channel-forming (cbv1) and accessory ß1 subunits cloned from rat cerebral artery myocytes. Leukotrienes were applied at 0.1 nm-10 µm to either leaflet of cell-free membranes at a wide range of [Ca(2+)]i and voltages. Only LTB4 reversibly increased BK steady-state activity (EC50 = 1 nm; Emax reached at 10 nm), with physiological [Ca(2+)]i and voltages favoring this activation. Homomeric cbv1 or cbv1-ß2 channels were LTB4-resistant. Computational modeling predicted that LTB4 docked onto the cholane steroid-sensing site in the BK ß1 transmembrane domain 2 (TM2). Co-application of LTB4 and cholane steroid did not further increase LTB4-induced activation. LTB4 failed to activate ß1 subunit-containing channels when ß1 carried T169A, A176S, or K179I within the docking site. Co-application of LTB4 with LTA4, LTC4, LTD4, or LTE4 suppressed LTB4-induced activation. Inactive leukotrienes docked onto a portion of the site, probably preventing tight docking of LTB4. In summary, we document the ability of two endogenous lipids from different chemical families to share their site of action on a channel accessory subunit. Thus, cross-talk between leukotrienes and cholane steroids might converge on regulation of smooth muscle contractility via BK ß1. Moreover, the identification of LTB4 as a highly potent ligand for BK channels is critical for the future development of ß1-specific BK channel activators.


Subject(s)
Ion Channel Gating/physiology , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/metabolism , Large-Conductance Calcium-Activated Potassium Channel beta Subunits/metabolism , Leukotriene B4/metabolism , Animals , Calcium/metabolism , Cerebral Arteries/cytology , Female , Ion Channel Gating/drug effects , Ion Channel Gating/genetics , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/chemistry , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/genetics , Large-Conductance Calcium-Activated Potassium Channel beta Subunits/chemistry , Large-Conductance Calcium-Activated Potassium Channel beta Subunits/genetics , Leukotriene A4/chemistry , Leukotriene A4/metabolism , Leukotriene A4/pharmacology , Leukotriene B4/chemistry , Leukotriene B4/pharmacology , Leukotriene C4/chemistry , Leukotriene C4/metabolism , Leukotriene C4/pharmacology , Leukotriene D4/chemistry , Leukotriene D4/metabolism , Leukotriene D4/pharmacology , Leukotriene E4/chemistry , Leukotriene E4/metabolism , Leukotriene E4/pharmacology , Membrane Potentials/drug effects , Microinjections , Models, Molecular , Molecular Structure , Muscle Cells/cytology , Muscle Cells/metabolism , Oocytes/drug effects , Oocytes/metabolism , Oocytes/physiology , Patch-Clamp Techniques , Protein Binding , Protein Structure, Tertiary , RNA, Complementary/administration & dosage , RNA, Complementary/genetics , Rats , Xenopus laevis
4.
Biochemistry ; 53(27): 4407-19, 2014 Jul 15.
Article in English | MEDLINE | ID: mdl-24893149

ABSTRACT

5-Lipoxygenase (5-LOX) reacts with arachidonic acid (AA) to first generate 5(S)-hydroperoxy-6(E),8(Z),11(Z),14(Z)-eicosatetraenoic acid [5(S)-HpETE] and then an epoxide from 5(S)-HpETE to form leukotriene A4, from a single polyunsaturated fatty acid. This work investigates the kinetic mechanism of these two processes and the role of ATP in their activation. Specifically, it was determined that epoxidation of 5(S)-HpETE (dehydration of the hydroperoxide) has a rate of substrate capture (Vmax/Km) significantly lower than that of AA hydroperoxidation (oxidation of AA to form the hydroperoxide); however, hyperbolic kinetic parameters for ATP activation indicate a similar activation for AA and 5(S)-HpETE. Solvent isotope effect results for both hydroperoxidation and epoxidation indicate that a specific step in its molecular mechanism is changed, possibly because of a lowering of the dependence of the rate-limiting step on hydrogen atom abstraction and an increase in the dependency on hydrogen bond rearrangement. Therefore, changes in ATP concentration in the cell could affect the production of 5-LOX products, such as leukotrienes and lipoxins, and thus have wide implications for the regulation of cellular inflammation.


Subject(s)
Adenosine Triphosphate/chemistry , Arachidonate 5-Lipoxygenase/chemistry , Arachidonic Acid/chemistry , Leukotrienes/chemistry , Allosteric Regulation , Calcium/chemistry , Enzyme Activation , Epoxy Compounds/chemistry , Humans , Leukotriene A4/chemistry , Peroxides/chemistry , Stereoisomerism , Viscosity
5.
Eur Respir J ; 44(2): 394-404, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24696116

ABSTRACT

Airway disease in cystic fibrosis (CF) is characterised by impaired mucociliary clearance, persistent bacterial infection and neutrophilic inflammation. Lipoxin A4 (LXA4) initiates the active resolution of inflammation and promotes airway surface hydration in CF models. 15-Lipoxygenase (LO) plays a central role in the "class switch" of eicosanoid mediator biosynthesis from leukotrienes to lipoxins, initiating the active resolution of inflammation. We hypothesised that defective eicosanoid mediator class switching contributes to the failure to resolve inflammation in CF lung disease. Using bronchoalveolar lavage (BAL) samples from 46 children with CF and 19 paediatric controls we demonstrate that the ratio of LXA4 to leukotriene B4 (LTB4) is depressed in CF BAL (p<0.01), even in the absence of infection (p<0.001). Furthermore, 15-LO2 transcripts were significantly less abundant in CF BAL samples (p<0.05). In control BAL, there were positive relationships between 15-LO2 transcript abundance and LXA4/LTB4 ratio (p=0.01, r=0.66) and with percentage macrophage composition of the BAL fluid (p<0.001, r=0.82), which were absent in CF. Impoverished 15-LO2 expression and depression of the LXA4/LTB4 ratio are observed in paediatric CF BAL. These observations provide mechanistic insights into the failure to resolve inflammation in the CF lung.


Subject(s)
Arachidonate 15-Lipoxygenase/metabolism , Cystic Fibrosis/blood , Leukotriene B4/chemistry , Lipoxins/chemistry , Anti-Bacterial Agents/therapeutic use , Bronchoalveolar Lavage Fluid/chemistry , Child , Child, Preschool , Cystic Fibrosis/metabolism , Cystic Fibrosis/physiopathology , Female , Humans , Inflammation , Leukotriene A4/chemistry , Longitudinal Studies , Lung/immunology , Lung/pathology , Lung Diseases/microbiology , Macrophages, Alveolar/metabolism , Male , Neutrophils/cytology , Neutrophils/metabolism
6.
J Biol Chem ; 289(8): 5199-207, 2014 Feb 21.
Article in English | MEDLINE | ID: mdl-24366866

ABSTRACT

Leukotriene (LT) C4 synthase (LTC4S) catalyzes the conjugation of the fatty acid LTA4 with the tripeptide GSH to produce LTC4, the parent compound of the cysteinyl leukotrienes, important mediators of asthma. Here we mutated Trp-116 in human LTC4S, a residue proposed to play a key role in substrate binding, into an Ala or Phe. Biochemical and structural characterization of these mutants along with crystal structures of the wild type and mutated enzymes in complex with three product analogs, viz. S-hexyl-, 4-phenyl-butyl-, and 2-hydroxy-4-phenyl-butyl-glutathione, provide new insights to binding of substrates and product, identify a new conformation of the GSH moiety at the active site, and suggest a route for product release, aided by Trp-116.


Subject(s)
Glutathione Transferase/chemistry , Glutathione/analogs & derivatives , Biocatalysis , Crystallography, X-Ray , Glutathione/metabolism , Glutathione Transferase/metabolism , Humans , Kinetics , Leukotriene A4/chemistry , Leukotriene C4/chemistry , Models, Molecular , Mutant Proteins/chemistry , Mutant Proteins/metabolism , Protein Conformation , Substrate Specificity , Tryptophan/metabolism
7.
J Lipid Res ; 54(3): 754-761, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23242647

ABSTRACT

Leukotriene (LT)A4 and closely related allylic epoxides are pivotal intermediates in lipoxygenase (LOX) pathways to bioactive lipid mediators that include the leukotrienes, lipoxins, eoxins, resolvins, and protectins. Although the structure and stereochemistry of the 5-LOX product LTA4 is established through comparison to synthetic standards, this is the exception, and none of these highly unstable epoxides has been analyzed in detail from enzymatic synthesis. Understanding of the mechanistic basis of the cis or trans epoxide configuration is also limited. To address these issues, we developed methods involving biphasic reaction conditions for the LOX-catalyzed synthesis of LTA epoxides in quantities sufficient for NMR analysis. As proof of concept, human 15-LOX-1 was shown to convert 15S-hydroperoxy-eicosatetraenoic acid (15S-HPETE) to the LTA analog 14S,15S-trans-epoxy-eicosa-5Z,8Z,10E,12E-tetraenoate, confirming the proposed structure of eoxin A4. Using this methodology we then showed that recombinant Arabidopsis AtLOX1, an arachidonate 5-LOX, converts 5S-HPETE to the trans epoxide LTA4 and converts 5R-HPETE to the cis epoxide 5-epi-LTA4, establishing substrate chirality as a determinant of the cis or trans epoxide configuration. The results are reconciled with a mechanism based on a dual role of the LOX nonheme iron in LTA epoxide biosynthesis, providing a rational basis for understanding the stereochemistry of LTA epoxide intermediates in LOX-catalyzed transformations.


Subject(s)
Epoxy Compounds/chemistry , Leukotriene A4/chemistry , Leukotriene A4/metabolism , Magnetic Resonance Spectroscopy/methods , Epoxy Compounds/metabolism , Gas Chromatography-Mass Spectrometry , Humans , Hydroxyeicosatetraenoic Acids/chemistry , Hydroxyeicosatetraenoic Acids/metabolism , Lipoxygenase/metabolism , Stereoisomerism
8.
PLoS One ; 7(7): e41063, 2012.
Article in English | MEDLINE | ID: mdl-22848428

ABSTRACT

Human leukotriene A4 hydrolase (hLTA4H), which is the final and rate-limiting enzyme of arachidonic acid pathway, converts the unstable epoxide LTA4 to a proinflammatory lipid mediator LTB4 through its hydrolase function. The LTA4H is a bi-functional enzyme that also exhibits aminopeptidase activity with a preference over arginyl tripeptides. Various mutations including E271Q, R563A, and K565A have completely or partially abolished both the functions of this enzyme. The crystal structures with these mutations have not shown any structural changes to address the loss of functions. Molecular dynamics simulations of LTA4 and tripeptide complex structures with functional mutations were performed to investigate the structural and conformation changes that scripts the observed differences in catalytic functions. The observed protein-ligand hydrogen bonds and distances between the important catalytic components have correlated well with the experimental results. This study also confirms based on the structural observation that E271 is very important for both the functions as it holds the catalytic metal ion at its location for the catalysis and it also acts as N-terminal recognition residue during peptide binding. The comparison of binding modes of substrates revealed the structural changes explaining the importance of R563 and K565 residues and the required alignment of substrate at the active site. The results of this study provide valuable information to be utilized in designing potent hLTA4H inhibitors as anti-inflammatory agents.


Subject(s)
Epoxide Hydrolases/chemistry , Inflammation Mediators/chemistry , Leukotriene A4/chemistry , Molecular Dynamics Simulation , Amino Acid Substitution , Catalysis , Catalytic Domain , Epoxide Hydrolases/genetics , Epoxide Hydrolases/metabolism , Humans , Inflammation Mediators/metabolism , Leukotriene A4/genetics , Leukotriene A4/metabolism , Mutation, Missense , Peptides/chemistry , Peptides/genetics , Peptides/metabolism , Protein Binding
9.
Chem Biol Drug Des ; 80(6): 902-8, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22913921

ABSTRACT

A combined molecular docking and molecular structure in silico analysis on the substrate and product of leukotriene A4 hydrolase (LTA4H) was performed. The molecular structures of the substrate leukotriene A4 (LTA4) and product leukotirene B4 (LTB4) were studied through density functional theory (DFT) calculations at the B3LYP/6-31 + G(d) level of theory in both gas and condensed phases. The whole LTB4 molecule was divided into three fragments (hydrophobic tail, triene motif, and a polar acidic group) that were subjected to a full conformational study employing the most stable conformations of them to build conformers of the complete molecule and geometry optimize further. LTA4 conformers' structures were modeled from the LTB4 minimum energy conformers. Both protonated and deprotonated species of LTA4 and LTB4 were analyzed according to pKa values found in the literature. Finally, a binding model of LTA4 with LTA4 hydrolase is proposed according to docking results that show intermolecular interactions that position the protonated and deprotonated ligand in the active site, in excellent agreement with the model suggested from LTA4H-inhibitors crystallographic data.


Subject(s)
Epoxide Hydrolases/chemistry , Leukotriene A4/chemistry , Binding Sites , Epoxide Hydrolases/metabolism , Hydrophobic and Hydrophilic Interactions , Leukotriene A4/metabolism , Molecular Conformation , Molecular Docking Simulation , Protein Structure, Tertiary , Thermodynamics
10.
Environ Mol Mutagen ; 51(4): 338-43, 2010 May.
Article in English | MEDLINE | ID: mdl-20120015

ABSTRACT

Leukotriene A(4) (LTA(4)), a reactive electrophilic intermediate formed during the biosynthesis of inflammation-related lipid mediators, has been found to bind covalently to DNA. The major DNA adducts formed by LTA(4) in vitro and human cells have been identified by mass spectrometry on the nucleoside level. Here we investigated whether the thin-layer chromatography (TLC) (32)P-postlabeling method is suitable for the detection of LTA(4)-DNA adducts. The reaction of individual deoxynucleoside 3'-monophosphates with LTA(4) in aqueous basic solution yielded numerous adduct spots when analyzed by the two enrichment procedures of the (32)P-postlabeling method-nuclease P1 digestion and butanol extraction. Highest LTA(4)-adduct levels were found with deoxyguanosine 3'-phosphate (around one adduct per 10(4) normal nucleotides). Under similar reaction conditions LTA(4) (25-320 microM) was incubated with calf thymus DNA, then DNA adduct patterns and levels were determined with the TLC (32)P-postlabeling method using both enrichment versions. The same DNA adduct pattern consisting of up to seven spots was observed with both enrichment versions. DNA adduct formation by LTA(4) was concentration-dependent with major adducts being derived from deoxyguanosine. When a human monocytic cell line (Mono Mac 6) was stimulated with arachidonic acid and calcium ionophore LTA(4)-DNA adducts were detected by (32)P-postlabeling. However, the level of these endogenously formed DNA adducts was close to the detection limit (3 +/- 2 adducts per 10(8) normal nucleotides). In summary, the TLC (32)P-postlabeling method is suitable for studying DNA adduct formation by LTA(4) and can be used for further investigations on the link between inflammation and cancer.


Subject(s)
Chromatography, Thin Layer/methods , DNA Adducts/analysis , Leukotriene A4/metabolism , Cell Line , DNA/chemistry , DNA Adducts/isolation & purification , DNA Adducts/metabolism , Dinucleoside Phosphates/chemistry , Humans , Leukotriene A4/chemistry , Phosphorus Radioisotopes
11.
J Lipid Res ; 50(10): 2064-71, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19269927

ABSTRACT

Leukotriene A(4) (LTA(4)) is the precursor for the formation of bioactive leukotrienes, but is highly susceptible to nonenzymatic hydrolysis. Although it is chemically reactive, LTA(4) participates in the process of transcellular metabolism, which requires the transfer of LTA(4) from one cell to another for the production of additional leukotrienes. Due to the susceptibility of LTA(4) to hydrolysis, various methods have been used to measure the half-life of LTA(4) in the presence of different proteins in efforts to understand how it is transported between cells. In this work, a new liquid chromatography mass spectrometry technique was developed to improve upon these previous assays that analyzed LTA(4) directly. The new technique derivatizes LTA(4) to stable compounds for analysis and removes the potential for sample decomposition between analytical runs. This assay was used in measuring the capabilities of the S100A8/A9 protein complex isolated from human neutrophils to stabilize LTA(4). It was determined that the S100A8/A9 protein complex protects LTA(4) from hydrolysis in a Ca(2+) dependent manner and increases LTA(4) half-life to in excess of 35 and 5 min at 4 degrees C and 37 degrees C, respectively.


Subject(s)
Calgranulin A/metabolism , Calgranulin B/metabolism , Leukotriene A4/chemistry , Leukotriene A4/metabolism , Blotting, Western , Calgranulin A/chemistry , Calgranulin B/chemistry , Cells, Cultured , Chromatography, Liquid , Humans , Mass Spectrometry , Protein Stability , Tandem Mass Spectrometry
12.
Biochemistry ; 47(32): 8445-55, 2008 Aug 12.
Article in English | MEDLINE | ID: mdl-18616291

ABSTRACT

In addition to orchestrating an adaptive metabolic response to xenobiotic compounds, the aryl hydrocarbon receptor (AHR) also plays a necessary role in the normal physiology of mice. The AHR is activated by a structurally diverse group of chemicals ranging from carcinogenic environmental pollutants to dietary metabolites and a number of endogenous molecules. Leukotriene A 4 (5,6-LTA 4) metabolites were identified in DRE-driven luciferase reporter assays as activators of AHR signaling. Various LTA 4 metabolites, including several 5,6- and 5,12-DiHETE products, were screened for AHR activity with 6- trans-LTB 4, 6- trans-12- epi-LTB 4, 5( S),6( S)-DiHETE, and 5( S),6( R)-DiHETE eliciting a significant level of AHR transcriptional activity. However, electrophoretic mobility shift assays (EMSAs) revealed that only 5,6-DiHETE isomers were capable of directly binding and activating the AHR to a DNA-binding species in vitro. Furthermore, ligand competition binding experiments confirm the ability of these compounds to directly bind to the AHR. Interestingly, "aged" preparations of 5,6-DiHETE isomers produced an enhanced level of AHR activation while demonstrating an increase in binding affinity for the receptor. Although the reason for this has not been fully determined, the formation of geometric isomers in the conjugated triene region of these molecules may play a role in the observed increase in AHR-mediated transcriptional activity. This work suggests a connection between AHR activation and inflammatory signaling molecules produced by the 5-lipoxygenase pathway.


Subject(s)
Leukotriene A4/metabolism , Receptors, Aryl Hydrocarbon/chemistry , Receptors, Aryl Hydrocarbon/metabolism , Binding, Competitive , Cell Line, Tumor , Cells, Cultured , Epoxide Hydrolases/metabolism , Humans , Isomerism , Leukotriene A4/chemistry , Leukotriene A4/genetics , Ligands , Nuclear Envelope/chemistry , Nuclear Envelope/metabolism , Protein Binding , Receptors, Aryl Hydrocarbon/genetics
13.
Anal Biochem ; 364(2): 204-12, 2007 May 15.
Article in English | MEDLINE | ID: mdl-17376394

ABSTRACT

Leukotrienes are important mediators in a number of inflammatory diseases and therefore are a target of several therapeutic approaches. The first committed step in the synthesis of leukotrienes is the conversion of arachidonic acid to leukotriene A(4) (LTA(4)) in two successive reactions catalyzed by 5-lipoxygenase (5-LOX). Assays to measure 5-LOX activity typically have been low throughput and time consuming. In this article, we describe a fluorescence assay that is amenable to high-throughput screening in a 384-well microplate format. The fluorescent signal is measured during oxidation of 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) by human 5-LOX. The assay has been found to reliably identify small molecule inhibitors of human 5-LOX. The IC(50) values of several 5-LOX inhibitors in this new assay are comparable to those determined in a standard spectrophotometric assay that measures the formation of the 5(S)-hydroperoxyeicosatetraenoic acid (5-HpETE) product. In addition, we demonstrate the use of the assay in a high-throughput screen of the Pfizer compound collection to identify inhibitors of 5-LOX.


Subject(s)
Arachidonate 5-Lipoxygenase/isolation & purification , Lipoxygenase Inhibitors/analysis , Lipoxygenase Inhibitors/chemistry , Spectrophotometry, Ultraviolet/methods , Chromogenic Compounds/chemistry , Cloning, Molecular/methods , Drug Evaluation, Preclinical/methods , Fluoresceins/chemistry , Fluorescence , Fluorescent Dyes/analysis , Fluorescent Dyes/chemistry , Humans , Indicators and Reagents , Inhibitory Concentration 50 , Leukotriene A4/chemistry , Leukotrienes/chemistry , Sensitivity and Specificity , Substrate Specificity
14.
Peptides ; 27(7): 1701-9, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16597475

ABSTRACT

Saccharomyces cerevisiae leukotriene A4 hydrolase (LTA4H) is a bifunctional aminopeptidase/epoxide hydrolase and a member of the M1 family of metallopeptidases. In order to obtain a more thorough understanding of the aminopeptidase activity of the enzyme, two conserved tyrosine residues, Tyr244 and Tyr456, were altered to phenylalanine and the mutant proteins characterized by determining KM and kcat for various amino acid beta-naphthylamide substrates. While mutation of Tyr456 exhibited minimal effect on catalysis, mutation of Tyr244 caused an overall 25-100-fold reduction in catalytic activity for all substrates tested. Furthermore, LTA4H Y244F exhibited a 40-fold decrease in affinity for RB-3014, a transition state analog inhibitor, implicating Tyr244 in transition state stabilization.


Subject(s)
Epoxide Hydrolases/metabolism , Peptide Hydrolases/chemistry , Saccharomyces cerevisiae/metabolism , Tyrosine/chemistry , Amino Acid Sequence , Binding Sites , Catalysis , Conserved Sequence , Enzyme Inhibitors/pharmacology , Kinetics , Leukotriene A4/chemistry , Molecular Sequence Data , Mutation , Sequence Homology, Amino Acid
15.
Biochem Biophys Res Commun ; 338(1): 144-8, 2005 Dec 09.
Article in English | MEDLINE | ID: mdl-16143298

ABSTRACT

Arachidonate 8-lipoxygenase was identified in phorbol ester induced mouse skin. We expressed the enzyme in an Escherichia coli system using pET-15b carrying an N-terminal histidine-tag sequence. The enzyme, purified by nickel-nitrilotriacetate affinity chromatography, showed specific activity of about 0.1 micromol/min/mg of protein with arachidonic acid as a substrate. When metabolites of arachidonic acid were reduced and analyzed by reverse-phase HPLC, 8-hydroxy derivative was a major product as measured by absorbance at 235 nm. In addition, three polar compounds (I, II, and III) were detected by measuring absorbance at 270 nm. These compounds were also produced when the enzyme was incubated with 8-hydroperoxyeicosa-5,9,11,14-tetraenoic acid. Neither heat-inactivated enzyme nor mutated enzyme produced these compounds, suggesting that they are enzymatically generated. Ultraviolet spectra of these compounds showed typical triplet peaks around 270 nm, indicating that they have a triene structure. Molecular weight of these compounds was determined to be 336 by liquid chromatography-mass spectrometry, indicating that they carry two hydroxyl groups. Compounds I and III were generated even under anaerobic condition, indicating that oxygenation reaction was not required for their generation from 8-hydroperoxyeicosa-5,9,11,14-tetraenoic acid. By analogy to the reactions of 5-lipoxygenase pathway where leukotriene A4 is generated, it is suggested that 8-hydroperoxyeicosa-5,9,11,14-tetraenoic acid is converted by the 8-lipoxygenase to 8,9-epoxyeicosa-5,10,12,14-tetraenoic acid which degrades to compounds I and III by non-enzymatic reaction. In contrast, compound II was not generated under anaerobic condition, indicating that it was produced by oxygenation reaction. Taken together, 8-lipoxygenase catalyzes both dehydration reaction to yield 8,9-epoxy derivative and oxygenation reaction presumably at 15-position of 8-hydroperoxyeicosa-5,9,11,14-tetraenoic acid.


Subject(s)
Leukotriene A4/biosynthesis , Lipoxygenase/metabolism , Animals , Arachidonic Acid/metabolism , Chromatography, High Pressure Liquid , Leukotriene A4/chemistry , Leukotrienes/metabolism , Lipoxygenase/chemistry , Lipoxygenase/genetics , Lipoxygenase/isolation & purification , Mice , Mutagenesis, Site-Directed
16.
Anal Biochem ; 333(1): 156-64, 2004 Oct 01.
Article in English | MEDLINE | ID: mdl-15351292

ABSTRACT

An assay was developed using electrospray ionization negative ion tandem mass spectrometry (MS) to identify and quantitate the major product in the reaction of leukotriene A(4) (LTA(4)) with deoxyguanosine (dGuo). A second quantitative assay was established using the same separation and detection techniques to determine the amount of dGuo isolated from enzymatically processed DNA. The amount of LTA(4)-dGuo adduct could then be analytically determined in DNA samples and normalized to the amount of dGuo that had been simultaneously derived from the DNA sample. Stable isotope-labeled internal standards used for these quantitative assays were readily synthesized from isotopically labeled [(15)N(5)(13)C(10)]deoxyguanosine triphosphate and analyzed for isotopic purity using MS. A comparison of fragment ions formed from stable isotope analogs of dGuo revealed the loss of deoxyribose and secondarily the loss of a series of stable neutral small molecules in a fashion similar to patterns described previously for the collisional fragmentation of protonated guanine determined by positive ion fast atom bombardment/MS/MS. The combined quantitative assays were used for the determination of the amount of endogenously formed LTA(4)-dGuo adducts observed in DNA when isolated human neutrophils that had been incubated with arachidonic acid were stimulated with calcium ionophore to initiate leukotriene biosynthesis.


Subject(s)
DNA Adducts/chemistry , Deoxyguanosine/chemistry , Leukotriene A4/chemistry , Spectrometry, Mass, Electrospray Ionization/methods , Arachidonic Acid/pharmacology , Cells, Cultured , Humans , Ionophores/pharmacology , Leukotriene A4/biosynthesis , Neutrophils/chemistry , Neutrophils/metabolism , Reference Standards , Sensitivity and Specificity
17.
J Lipid Res ; 45(11): 2138-44, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15342681

ABSTRACT

Leukotriene A(4) (LTA(4)) is a chemically reactive conjugated triene epoxide product derived from 5-lipoxygenase oxygenation of arachidonic acid. At physiological pH, this reactive compound has a half-life of less than 3 s at 37 degrees C and approximately 40 s at 4 degrees C. Regardless of this aqueous instability, LTA(4) is an intermediate in the formation of biologically active leukotrienes, which can be formed through either intracellular or transcellular biosynthesis. Previously, epithelial fatty acid binding protein (E-FABP) present in RBL-1 cells was shown to increase the half-life of LTA(4) to approximately 20 min at 4 degrees C. Five FABPs (adipocyte FABP, intestinal FABP, E-FABP, heart/muscle FABP, and liver FABP) have now been examined and also found to increase the half-life of LTA(4) at 4 degrees C to approximately 20 min with protein present. Stabilization of LTA(4) was examined when arachidonic acid was present to compete with LTA(4) for the binding site on E-FABP. Arachidonate has an apparent higher affinity for E-FABP than LTA(4) and was able to completely block stabilization of the latter. When E-FABP is not saturated with arachidonate, FABP can still stabilize LTA(4). Several lipoxygenase products, including 5-hydroxyeicosatetraenoic acid, 5,6-dihydroxyeicosatetraenoic acid, and leukotriene B(4), were found to have no effect on the stability of LTA(4) induced by E-FABP even when present at concentrations 3-fold higher than LTA(4).


Subject(s)
Arachidonic Acid/metabolism , Carrier Proteins/physiology , Leukotriene A4/metabolism , Lipoxygenase/metabolism , Animals , Binding Sites , Binding, Competitive , Biochemical Phenomena , Biochemistry , Cell Line , Dose-Response Relationship, Drug , Fatty Acid-Binding Proteins , Hydrogen-Ion Concentration , Hydroxyeicosatetraenoic Acids/pharmacology , Leukotriene A4/chemistry , Mass Spectrometry , Models, Biological , Protein Binding , Rats , Temperature , Time Factors
18.
J Biol Chem ; 279(9): 7420-6, 2004 Feb 27.
Article in English | MEDLINE | ID: mdl-14676186

ABSTRACT

Leukotriene A(4) (LTA(4)) is a chemically unstable triene epoxide product of 5-lipoxygenase metabolism of arachidonic acid. Despite this chemical reactivity and its synthesis at the perinuclear membrane, LTA(4) is enzymatically converted into the cysteinyl leukotrienes and leukotriene B(4). Furthermore, LTA(4) participates in transcellular biosynthesis and is thus transferred between cells as an intact molecule. A cytosolic fatty acid-binding protein present in the rat basophilic leukemia cells was identified using mass spectrometry. This protein was determined to be the stabilizing factor present in the cell cytosol responsible for increasing the effective chemical half-life of LTA(4). Rat epithelial fatty acid-binding protein (E-FABP) was isolated using partial protein purification and immunoprecipitation. In-gel digestion with trypsin followed by peptide fingerprint analysis using matrix-assisted laser desorption ionization mass spectrometry and sequencing the major tryptic peptide obtained from liquid chromatography/mass spectrometry/mass spectrometry analysis identified E-FABP in the active fraction. Semi-quantitative Western blot analysis indicated that E-FABP in the cytosolic fraction of RBL-1 cells was present at approximately 1-3 pmol/10(6) cells. E-FABP (9 microm) was tested for its ability to stabilize LTA(4), and at 37 degrees C E-FABP was able to increase the half-life of LTA(4) from the previously reported half-life less than 3 s to a half-life of approximately 7 min. These results present a novel function for the well studied fatty acid-binding protein as a participant in leukotriene biosynthesis that permits LTA(4) to be available for further enzymatic processing in various cellular regions.


Subject(s)
Carrier Proteins/physiology , Eye Proteins , Leukemia, Basophilic, Acute/metabolism , Leukotriene A4/metabolism , Nerve Tissue Proteins , Animals , Blotting, Western , Carrier Proteins/analysis , Carrier Proteins/pharmacology , Chromatography, High Pressure Liquid , Cytosol/chemistry , Electrophoresis, Polyacrylamide Gel , Fatty Acid-Binding Proteins , Half-Life , Immunosorbent Techniques , Leukotriene A4/chemistry , Mass Spectrometry , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Peptide Mapping , Rats , Sequence Analysis, Protein , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Trypsin/metabolism , Tumor Cells, Cultured
20.
Chem Res Toxicol ; 16(4): 551-61, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12703973

ABSTRACT

Leukotriene A(4) (LTA(4)) is a highly reactive electrophilic intermediate formed during the biosynthesis of the lipid mediators leukotriene B(4) and leukotriene C(4). Deoxynucleosides were found to react as nucleophiles with LTA(4) in aqueous solutions as assessed by UV spectroscopy and electrospray ionization mass spectrometry. Aqueous solutions of native DNA and RNA were also found to react with LTA(4) as assessed by mass spectrometric analysis of the constituent nucleosides derived from enzymatic hydrolysis of the nucleic acids. The most abundant adducts were observed for guanine- and adenine-containing deoxynucleosides and nucleosides. At neutral pH, these reactions led to an overall modification of deoxyguanosine/guanosine residues in DNA and RNA at 15 +/- 1 adducts/10(7) bases and 230 +/- 20 adducts/10(7) bases, respectively, determined by quantitative assay using stable isotope-labeled LTA(4)-nucleoside adduct. An estimation of the relative reactivity of LTA(4) with each of the purine and pyrimidine bases in DNA and RNA was carried out by comparisons of the mass spectral ion abundance of the different adducts (LTA(4)-dAdo, LTA(4)-dCyd, LTA(4)-Thd, LTA(4)-Ado, LTA(4)-Cyd, and LTA(4)-Urd) to the ion signal of known amounts of LTA(4)-dGuo and LTA(4)-Guo standards. The data were corrected for different mass spectrometric response factors that were experimentally determined for each adduct product. The structures of the two most abundant LTA(4)-Guo products were determined by NMR, UV spectroscopy, and mass spectrometry to be 5-hydroxy,12-[Guo-N(2)-yl]-6,8,11,14-eicosatetraenoic acid. Stimulation of human neutrophils with calcium ionophore led to the covalent modification of DNA within the cell as determined by mass spectrometric analysis of lipophilic nucleosides obtained after hydrolysis of extracted DNA. These observations, combined with the intracellular site of 5-lipoxygenase translocation and LTA(4) biosynthesis at the nuclear envelope, suggest that LTA(4) may have access to DNA and RNA within cells and furthermore modify nucleic acids in situ following the activation of 5-lipoxygenase and initiation of LTA(4) biosynthesis.


Subject(s)
DNA/chemistry , Leukotriene A4/chemistry , RNA/chemistry , Calcimycin/pharmacology , Chromatography, High Pressure Liquid , DNA/metabolism , DNA Adducts/chemistry , DNA Adducts/isolation & purification , Guanosine/chemistry , Humans , In Vitro Techniques , Ionophores/pharmacology , Kinetics , Leukotriene A4/metabolism , Magnetic Resonance Spectroscopy , Mass Spectrometry , Neutrophil Activation , Neutrophils/metabolism , Spectrophotometry, Ultraviolet
SELECTION OF CITATIONS
SEARCH DETAIL
...